286 related articles for article (PubMed ID: 19910122)
1. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
Bishayee A; Politis T; Darvesh AS
Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
[TBL] [Abstract][Full Text] [Related]
2. Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.
Bishayee A; Thoppil RJ; Waghray A; Kruse JA; Novotny NA; Darvesh AS
Curr Cancer Drug Targets; 2012 Nov; 12(9):1191-232. PubMed ID: 22873222
[TBL] [Abstract][Full Text] [Related]
3. Selenium in the prevention and treatment of hepatocellular carcinoma.
Darvesh AS; Bishayee A
Anticancer Agents Med Chem; 2010 May; 10(4):338-45. PubMed ID: 20380634
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.
Darvesh AS; Bishayee A
Nutr Cancer; 2013; 65(3):329-44. PubMed ID: 23530632
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and liver cancer: a review.
Darvesh AS; Aggarwal BB; Bishayee A
Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Luther DJ; Ohanyan V; Shamhart PE; Hodnichak CM; Sisakian H; Booth TD; Meszaros JG; Bishayee A
Invest New Drugs; 2011 Apr; 29(2):380-91. PubMed ID: 19812893
[TBL] [Abstract][Full Text] [Related]
7. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).
Aziz MH; Kumar R; Ahmad N
Int J Oncol; 2003 Jul; 23(1):17-28. PubMed ID: 12792772
[TBL] [Abstract][Full Text] [Related]
8. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis.
Mbimba T; Awale P; Bhatia D; Geldenhuys WJ; Darvesh AS; Carroll RT; Bishayee A
Curr Pharm Biotechnol; 2012 Jan; 13(1):229-34. PubMed ID: 21466437
[TBL] [Abstract][Full Text] [Related]
9. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
Mastron JK; Siveen KS; Sethi G; Bishayee A
Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
[TBL] [Abstract][Full Text] [Related]
10. Has selenium a chemopreventive effect on hepatocellular carcinoma?
Costantini S; Lepore MG; Castello G; Colonna G
Mini Rev Med Chem; 2011 Jun; 11(7):599-610. PubMed ID: 21699491
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
12. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.
Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O
Nutr Cancer; 2008; 60(6):729-35. PubMed ID: 19005972
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism.
Yu HB; Zhang HF; Zhang X; Li DY; Xue HZ; Pan CE; Zhao SH
Hepatogastroenterology; 2010; 57(102-103):1241-6. PubMed ID: 21410066
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
Bishayee A; Dhir N
Chem Biol Interact; 2009 May; 179(2-3):131-44. PubMed ID: 19073162
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy.
Bishayee A; Darvesh AS
Curr Cancer Drug Targets; 2012 Nov; 12(9):1095-118. PubMed ID: 22873221
[TBL] [Abstract][Full Text] [Related]
16. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis.
Mann CD; Neal CP; Garcea G; Manson MM; Dennison AR; Berry DP
Eur J Cancer Prev; 2009 Feb; 18(1):13-25. PubMed ID: 19077560
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
18. The potential of resveratrol against human gliomas.
Gagliano N; Aldini G; Colombo G; Rossi R; Colombo R; Gioia M; Milzani A; Dalle-Donne I
Anticancer Drugs; 2010 Feb; 21(2):140-50. PubMed ID: 20010425
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis.
Bishayee A; Waghray A; Barnes KF; Mbimba T; Bhatia D; Chatterjee M; Darvesh AS
Pharm Res; 2010 Jun; 27(6):1080-91. PubMed ID: 20405173
[TBL] [Abstract][Full Text] [Related]
20. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review.
Baby J; Devan AR; Kumar AR; Gorantla JN; Nair B; Aishwarya TS; Nath LR
J Food Biochem; 2021 Jul; 45(7):e13761. PubMed ID: 34028054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
